Management of Choroidal and Ciliary-Body Melanomas

References

• Scotto J, Fraumeni J F, Jr, Lee J AH. Melanomas of the eye and other noncutaneous sites: Epidemiologic aspects. J Natl Cancer Inst. 1976; 56: 489–491
   PubMedGoogle Scholar
• Cancer Statistics Review: 1973–1987. US Department of Health and Human Services, NIH publication number 90–2789
   Google Scholar
• Seddon J M, Gragoudas E S, Glynn R J, et al. Host factors, ultraviolet radiation and risk of uveal melanoma: A case-control study. Arch Ophthalmol. 1990; 108: 1274–1280
   PubMed Web of Science ®Google Scholar
• Raivio I. Uveal melanoma in Finland. An epidemiological, clinical, histological and prognostic study. Acta Ophthalmol. 1977; 133(suppl)3–64
   Google Scholar
• Jensen O A. Malignant melanomas of the human uvea: 25-year follow-up of cases in Denmark, 1943–1952. Acta Ophthalmol. 1982; 60: 161–182
   PubMed Web of Science ®Google Scholar
• Ganley J P, Comstock G W. Benign nevi and malignant melanomas of the choroid. Am J Ophthalmol. 1973; 76: 19–25
   PubMed Web of Science ®Google Scholar
• Gass J DM. Observation of suspected choroidal and ciliary body melanomas for evidence of growth prior to enucleation. Ophthalmology 1980; 87: 523–528
   Web of Science ®Google Scholar
• Meyer-Schwickerath G. Photocoagulation of choroidal melanomas. Doc Ophthalmol. 1980; 50: 57–61
   Web of Science ®Google Scholar
• Francois J. Treatment of malignant melanomas of the choroid by light coagulation. Mod Probl Ophthalmol. 1974; 12: 550–555
   Google Scholar
• Panagopoulos J A, Svitra P P, Puliafito C A, et al. Photodynamic therapy for experimental intraocular melanoma using chloroaluminum sulfonated phthalocyanine. Arch Ophthalmol 1989; 107: 886–890
   Google Scholar
• Tse D T, Dutton J J, Wiengeist T A, et al. Hematoporphyrin photoirradiation therapy for intraocular and orbital malignant melanoma. Arch Ophthalmol. 1984; 102: 833–838
   PubMed Web of Science ®Google Scholar
• Schmidt V, Bauman W, Gragoudas E, et al. Photodynamic therapy of experimental choroidal melanoma using a lipoprotein-delivered benzoporphyrin. Ophthalmology, (In press)
   Google Scholar
• Stallard H B. Pigmental tumors of the eye: Surgical aspects. Proc R Soc Med. 1961; 54: 463–467
   Google Scholar
• Peyman G A, Raichand M. Full-thickness eye wall resection of choroidal neoplasms. Ophthalmology 1979; 86: 1024–1036
   Google Scholar
• Foulds W S. Results of local excision of uveal tumors. Intraocular Tumors, P K Lommatzsch, F C Blodi. Akademie-Vertag, BerlinGermany 1983; 374–377
   Google Scholar
• Shields J A, Augsburger J J, Brady L W. Cobalt plaque therapy of posterior uveal melanomas. Ophthalmology 1982; 89: 1201–1207
   PubMed Web of Science ®Google Scholar
• Lommatzsch P K. B-irradiation of choroidal melanoma with 106Ru/106 Rh applicators; 16 years' experience. Arch Ophthalmol. 1983; 101: 713–717
   PubMed Web of Science ®Google Scholar
• Packers Rotman M, Salanitro P. Iodine-125 irradiation of choroidal melanoma; Clinical experience. Ophthalmology 1984; 91: 1700–1707
   Google Scholar
• Gragoudas E S, Goitein M, Verhey L, et al. Proton beam irradiation of uveal melanomas; results of a 5½year study. Arch Ophthalmol. 1982; 100: 928–934
   PubMedGoogle Scholar
• Char D H, Saunders W, Castro J R, et al. Helium ion therapy for choroidal melanoma. Ophthalmology 1983; 90: 1219–1225
   PubMedGoogle Scholar
• Wilkes S R, Gragoudas E S. Regression patterns of uveal melanomas after proton beam irradiation. Ophthalmology 1982; 89: 840–843
   PubMedGoogle Scholar
• Glynn R J, Seddon J M, Gragoudas E S, et al. Evaluation of tumor regression and other prognostic factors for early and late metastasis after proton beam irradiation of uveal melanoma. Ophthalmology 1989; 96: 1566–1573
   Google Scholar
• Gragoudas E S, Egan K M, Saornil M A, et al. The time course of irradiation changes in proton beam treated uveal melanomas. Ophthalmology, In press
   Google Scholar
• Gragoudas E S. Proton beam therapy of uveal melanomas. Arch Ophthalmol. 1986; 104: 349–351
   Google Scholar
• Goodman D F, Char D H, Crawford J B, et al. Uveal melanoma necrosis after helium ion therapy. Am J Ophthalmol. 1986; 101: 643–645
   Google Scholar
• Gragoudas E S, Seddon J M, Egan K, et al. Long-term results of proton beam irradiated uveal melanomas. Ophthalmology 1987; 94: 349–353
   PubMed Web of Science ®Google Scholar
• Char D H, Castro J R, Kroll S M, et al. Five-year follow-up of helium ion therapy for uveal melanoma. Arch Ophthalmol. 1990; 108: 209–214
   PubMedGoogle Scholar
• Guyer D R, Mukai S, Egan K M, et al. Radiation maculopathy following proton beam irradiation for choroidal melanoma. Ophthalmology 1992; 99: 760–766
   Google Scholar
• Kim M K, Char D H, Castro J R, et al. Neovascular glaucoma after helium ion irradiation for uveal melanoma. Ophthalmology 1986; 93: 189–193
   PubMedGoogle Scholar
• Gragoudas E S, Egan K, Arrigg P, et al. Cataract extraction after proton beam irradiation. Arch Ophthalmol. 1992; 110: 475–479
   Google Scholar
• Stallard H B. Radiotherapy for malignant melanoma of the choroid. Br J Ophthalmol. 1966; 50: 147–155
   PubMed Web of Science ®Google Scholar
• Stallard H B. Malignant melanoblastoma of the choroid. Bibl Ophthalmol. 1968; 75: 16–38
   Google Scholar
• McFaul P A, Beford M A. Ocular complications after therapeutic irradiation. Br J Ophthalmol. 1970; 54: 237–47
   Google Scholar
• Wilson R R. Radiological use of fast protons. Radiology 1946; 47: 487–491
   PubMed Web of Science ®Google Scholar
• Koehler A M, Schneider R J, Sisterson J M. Range modulators for protons and heavy ions. Nucl Instrum Meth. 1975; 131: 437–440
   Web of Science ®Google Scholar
• Gragoudas E S, Seddon J, Goitein M, et al. Current results of proton beam irradiation of uveal melanomas. Ophthalmology 1985; 92: 284–291
   PubMed Web of Science ®Google Scholar
• Brovkina A F, Zarubei G D. Ciliochoroidal melanomas treated with a narrow medical proton beam. Arch Ophthalmol. 1986; 104: 402–404
   PubMedGoogle Scholar
• Zografos L, Gailloud C L, Perret C H, et al. Rapport sur le traitement conservateur des melanomes de ľuvee a la clinique ophthalmologique universitaire de Lausanne. Klin Monatsbl Augenheilkd. 1988; 192: 572–578
   Google Scholar
• Seddon J M, Gragoudas E S, Polivogianis L, et al. Visual outcome after proton beam irradiation of uveal melanoma. Ophthalmology 1986; 93: 666–674
   Google Scholar
• Seddon J M, Gragoudas E S, Egan K M, et al. Uveal melanomas near the optic disc or fovea: visual results after proton beam irradiation. Ophthalmology 1987; 94: 354–361
   PubMed Web of Science ®Google Scholar
• Egan K M, Gragoudas E S, Seddon J M, et al. The risk of enucleation after proton beam irradiation of uveal melanoma. Ophthalmology 1989; 96: 1377–1383
   PubMed Web of Science ®Google Scholar
• Gragoudas E S, Egan K M, Seddon J M, et al. Intraocular recurrence of uveal melanoma after proton beam irradiation. Ophthalmology 1992; 99: 760–766
   PubMed Web of Science ®Google Scholar
• Gragoudas E S, Seddon J M, Egan K M, et al. Metastasis from uveal melanoma after proton beam irradiation. Ophthalmology 1988; 95: 992–999
   Google Scholar
• Gragoudas E S, Seddon J M, Egan K M, et al. Prognostic factors for metastasis following proton beam irradiation of uveal melanomas. Ophthalmology 1986; 93: 675–680
   Google Scholar
• Wilson R S, Fraunfelder F T. “No touch” cryosurgical enucleation: A minimal trauma technique for eyes harboring intraocular malignancy. Ophthalmology 1978; 85: 1170–1175
   Google Scholar
• Char D H, Phillips T L, Andejeski Y, et al. Failure of preenucleation radiation to decrease uveal melanoma mortality. Am J Ophthalmol. 1988; 106: 21–26
   PubMedGoogle Scholar
• Shammas H F, Blodi F C. Orbital extension of choroidal and ciliary body melanomas. Arch Ophthalmol. 1977; 95: 2002–2005
   PubMedGoogle Scholar
• Affeldt J C, Minckler D S, Azen S A, et al. Prognosis in uveal melanomas with extrascleral extension. Arch Ophthalmol. 1980; 98: 1975–1979
   PubMedGoogle Scholar
• Gragoudas E S, Egan K M, Seddon J M, et al. Survival of patients with metastases from uveal melanoma. Ophthalmology 1991; 98: 383–390
   PubMed Web of Science ®Google Scholar
• Mastroangelo M J, Schultz S, Kane M, et al. New immunologic approaches to the treatment of patients with melanoma. Semin Oncol. 1988; 15: 589–594
   Google Scholar
• Mitchell M S, Harel W, Kempf R A, et al. Active-specific immunotherapy for melanoma. J Clin Oncol. 1990; 8: 856–869
   PubMed Web of Science ®Google Scholar